• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION SMART CONTROL ILIAC; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION SMART CONTROL ILIAC; STENT, ILIAC Back to Search Results
Catalog Number C09040SL
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/15/2024
Event Type  Injury  
Event Description
As reported, a smart control, iliac 9 mm x 40 mm vascular stent was automatically getting released and the stent was deployed further than intended position.Therefore, an unknown 8 mm x 60 mm stent was added and implanted.The smart stent was being implanted at the common iliac artery.The complaint device was deployed approximate 1 cm and final positioning was being adjusted.However, the stent was automatically getting released and the stent was deployed further than intended position.An unknown 6f short sheath was used.Other procedural details were requested but are unknown, unavailable, not answered, or not applicable.The stent remained implanted; therefore, it will not be returned for evaluation.
 
Manufacturer Narrative
Additional information is pending and will be submitted within 30 days upon receipt.
 
Manufacturer Narrative
Complaint conclusion: as reported, a smart control, iliac 9 mm x 40 mm vascular stent was automatically getting released and the stent was deployed further than intended position.Therefore, an unknown 8 mm x 60 mm stent was added and implanted.The smart stent was being implanted at the common iliac artery.The complaint device was deployed approximate 1 cm and final positioning was being adjusted.However, the stent was automatically getting released and the stent was deployed further than intended position.An unknown 6f short sheath was used.Other procedural details were requested but are unknown, unavailable, not answered, or not applicable.The stent remained implanted; therefore, it will not be returned for evaluation.The reported event of ¿stent delivery system (sds)-deployment difficulty-premature/in patient¿ could not be confirmed as the device was not returned for analysis and procedural films of the reported event was not provided.The exact cause of the issue experienced could not be determined.Based on the information available for review, it is difficult to determine what factors may have contributed to the premature deployment of the stent reported.However, as 1cm of the stent was already deployed and the user was repositioning the device at the time of the issue, it is likely that procedural/handling factors (as the locking pin should be removed at this time) contributed to the reported event of the unintended deployment of the remainder of the stent.According to the instructions for use (ifu), it warns ¿the stent is not designed for repositioning or recapturing.Once the stent is partially deployed, it cannot be recaptured using the stent delivery system.¿ the ifu also instructs during stent deployment, ¿advance the stent delivery system past the lesion site.Pull back the stent delivery system until the radiopaque stent markers (leading and trailing ends) move in position so that they are proximal and distal to the lesion site.Ensure that the stent delivery system outside the patient remains flat and straight.Caution: slack in the catheter shaft either outside or inside the patient may result in deploying the stent beyond the lesion site.Verify that the delivery system¿s radiopaque stent markers (leading and trailing ends) are proximal and distal to the target lesion.Ensure that the introducer sheath does not move during deployment.Remove locking pin from handle.Initiate one-handed stent deployment by rotating the tuning dial with thumb and index fingers in a clockwise direction (direction of arrow) while holding the handle in a fixed position.While using fluoroscopy, maintain position of the radiopaque stent markers relative to the targeted lesion site.Watch for the distal radiopaque markers to begin separating.Separation of the distal stent markers signals that the stent is unsheathed.Continue turning the tuning dial until the distal end of the stent obtains full apposition with the vessel wall.Note: only the initial 40 mm of the stent may be unsheathed using the tuning dial.¿ based on the information available for review, there is no indication that the reported event could be related to the design or manufacturing process of the unit.Therefore, no corrective/preventative actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART CONTROL ILIAC
Type of Device
STENT, ILIAC
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 
7863138372
MDR Report Key18676294
MDR Text Key335015253
Report Number9616099-2024-00044
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberC09040SL
Device Lot Number18226352
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/16/2024
Initial Date FDA Received02/09/2024
Supplement Dates Manufacturer Received02/14/2024
Supplement Dates FDA Received02/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/24/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN 6F SHORT SHEATH.; UNKNOWN 8 MM X 60 CM STENT.
Patient Outcome(s) Life Threatening; Required Intervention;
-
-